<VariationArchive RecordType="classified" VariationID="417363" VariationName="NC_000023.10:g.(?_103031754)_(103047548_?)dup" VariationType="Duplication" Accession="VCV000417363" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-04-17" MostRecentSubmission="2017-04-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="404425" VariationID="417363">
      <GeneList>
        <Gene Symbol="PLP1" FullName="proteolipid protein 1" GeneID="5354" HGNC_ID="HGNC:9086" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="103776506" stop="103792619" display_start="103776506" display_stop="103792619" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="103031438" stop="103047547" display_start="103031438" display_stop="103047547" Strand="+" />
          </Location>
          <OMIM>300401</OMIM>
          <Haploinsufficiency last_evaluated="2021-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PLP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PLP1">Sufficient evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_103031754)_(103047548_?)dup</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="103031754" innerStop="103047548" display_start="103031754" display_stop="103047548" variantLength="15795" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_103031754)_(103047548_?)dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_103031754)_(103047548_?)dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_103031754)_(103047548_?)dup AND Hereditary spastic paraplegia 2" Accession="RCV000474773" Version="1">
        <ClassifiedConditionList TraitSetID="3068">
          <ClassifiedCondition DB="MedGen" ID="C1839264">Hereditary spastic paraplegia 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-05-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-05-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-04-17" MostRecentSubmission="2017-04-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3068" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5933" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 2</ElementValue>
                <XRef ID="Spastic+paraplegia+2/6686" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA 2, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="312920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 2</ElementValue>
                <XRef ID="MONDO:0010733" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPPX2</ElementValue>
                <XRef Type="MIM" ID="312920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SPG2</ElementValue>
                <XRef Type="MIM" ID="312920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4923" />
                <XRef ID="4923" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PLP1 disorders of central nervous system myelin formation include a range of phenotypes from Pelizaeus-Merzbacher disease (PMD) to spastic paraplegia 2 (SPG2). PMD typically manifests in infancy or early childhood with nystagmus, hypotonia, and cognitive impairment; the findings progress to severe spasticity and ataxia. Life span is shortened. SPG2 manifests as spastic paraparesis with or without CNS involvement and usually normal life span. Intrafamilial variation of phenotypes can be observed, but the signs are usually fairly consistent within families. Heterozygous females may manifest mild-to-moderate signs of the disease.</Attribute>
                <XRef ID="NBK1182" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301361</ID>
                <ID Source="BookShelf">NBK1182</ID>
              </Citation>
              <XRef ID="99015" DB="Orphanet" />
              <XRef ID="C1839264" DB="MedGen" />
              <XRef ID="MONDO:0010733" DB="MONDO" />
              <XRef Type="MIM" ID="312920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1076743" SubmissionDate="2017-03-14" DateLastUpdated="2017-04-17" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="291107|MedGen:C1839264" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000563826" DateUpdated="2017-04-17" DateCreated="2017-04-17" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">A gross duplication of the genomic region encompassing the full coding sequence of the PLP1 gene has been identified. The boundaries of this event are unknown as the duplication extends beyond the assayed region for this gene and therefore may encompass additional genes. As the precise location of this duplication is unknown, it may be in tandem or it may be located elsewhere in the genome. Whole gene duplication of PLP1 has been reported in many individuals affected with Pelizaeus-Merzbacher disease (PMID: 9634530, 10417279, 16380909, 18160035, 19328639). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLP1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_103031754)_(103047548_?)dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1839264" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2017March_Invitae</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1076743" TraitType="Disease" MappingType="XRef" MappingValue="C1839264" MappingRef="MedGen">
        <MedGen CUI="C1839264" Name="Hereditary spastic paraplegia 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

